ProVerum Medical
A study to collect data on the post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.
An analysis of US based subjects who exited from the ProVIDE or ProVIDE II studies.
Inclusion Criteria: * 1\. US based subjects previously enrolled in the ProVIDE Study or the ProVIDE II Bridging Study who had a ProVee device removed. * 2\. Subjects who withdrew consent or were withdrawn by site Study PI. * 3\. Subjects consented to make data available. Exclusion Criteria: * 1\. Incomplete records available. * 2\. Subjects who exited the studies due to restarting BPH medication while they were enrolled. * 3\. Subjects who did not receive a ProVee in the ProVIDE Study or the ProVIDE II Bridging Study. * 4\. Subjects who exited the studies due to prostate cancer.
ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.